Vir Biotechnology, Inc. (VIR) Stock Overview
Explore Vir Biotechnology, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Vir Biotechnology, Inc. (VIR)
Key Financials
Key Financials
Market Cap
1.5B
P/E Ratio
-2.86
EPS (TTM)
$-3.13
ROE
-0.53%
VIR Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Vir Biotechnology, Inc. (VIR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.99, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.52.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.86 and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.